Biotech

Category / Pharmaceuticals & Biotech / Biotech

Boston Therapeutics Receives $500,000 Equity Investment

MANCHESTER, NH: MANCHESTER, NH -- (Marketwire) -- 06/14/12 -- (OTCQB: BTHE) (OTCBB: BTHE) a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases, today announced that it has re ...

Lorus Therapeutics Announces Clinical Study Progress With Its Anticancer Drug LOR-253 and Expansion to a Second Major Site

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 06/14/12 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...

Prana's PBT2 Presented at the Huntington's Disease Society of America National Convention

MELBOURNE, AUSTRALIA: Prana's 'Reach2HD' Phase II Trial on Track ...

Immunovaccine to Present at Three Conferences in June

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwire) -- 06/13/12 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE: IMV), a clinical stage vaccine company, today announced th ...

Prima BioMed Ltd Shareholders' Briefing Webcast & Dial In Details

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 06/12/12 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) confirms the webcast and dial in details for the shareholder briefing to be held on Friday 15th June 2012, ...

Mediatum to Exhibit at BIO 2012 International Convention

CAMBRIDGE, MA: Life Sciences Executive Search Firm Will Be in Booth # 718 at the German Pavilion at Biotech Industry's Largest Annual Event ...

Emerald Bio Announces Unprecedented Multi-Target 3D Structural Biology Success

BEDFORD, MA: BEDFORD, MA -- (Marketwire) -- 06/12/12 -- announces early delivery of the 500th novel protein structure under the Seattle Structural Genomics Center for Infectious Disease (SSGCID), a consortium of ...

Foamtec Introduces Sahara Corrosion Cleaning System(SM)

OCEANSIDE, CA: OCEANSIDE, CA -- (Marketwire) -- 06/12/12 -- As Pharmaceutical and Biotech companies struggle to maintain their facilities in audit-ready conditions to comply with cGMP guidelines, one company has in ...

Cornerstone Therapeutics Appoints Dr. Laura Shawver to Board of Directors

CARY, NC: CARY, NC -- (Marketwire) -- 06/12/12 -- Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital, niche respiratory and related specialty markets ...

Cytokinetics Announces Publication of Phase II Evidence of Effect Study of CK-2017357 in the Journal Amyotrophic Lateral Sclerosis

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 06/12/12 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the publication of its Phase II Evidence of Effect (EoE) clinical study of CK-2017357, ...

Pharma-Biotech Capital Construction Investment Mid-Year Snapshot: 2012 Project Starts Near $15 Billion, an Industrial Info News Alert

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 06/12/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With 2012 almost halfway complete, the North American is holding its own. ...

FDA Approves Dako's HercepTest(TM) and HER2 FISH pharmDx(TM) Kit as Companion Diagnostics for Genentech's New Cancer Drug Perjeta(TM)

GLOSTRUP, DENMARK: GLOSTRUP, DENMARK -- (Marketwire) -- 06/11/12 -- Dako, a world leading provider of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest� ...

New Epidemiological Data Provide Additional Safety Evidence for Lantus(R)

PARIS, FRANCE: No Increased Risk of Cancer Found With Lantus(R) in New European and U.S. Observational Studies ...

Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Conference as Part of a Collaboration With Phage Pharmaceuticals

TUSTIN, CA: Custom Protein Production Service Offered for Research Grade and cGMP Production Using Proprietary Phage Expression System ...

Sanofi Announces Results of ORIGIN, the World's Longest and Largest Randomized Clinical Trial in Pre- and Early Diabetes

PARIS, FRANCE: PARIS, FRANCE -- (Marketwire) -- 06/11/12 -- Sanofi (EURONEXT: SAN) (NYSE: SNY) announced today results from the landmark ORIGIN trial (Outcome Reduction with Initial Glargine Intervention), which s ...

RepliCel Presents Further Clinical Data and Corporate Update at its Annual General Meeting of Shareholders

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 06/11/12 -- (the "Company" or "RepliCel") (OTCBB: REPCF) presented significant new data from its Phase I/IIa first-in-man clinical ...

Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose

PARIS, FRANCE: Lixisenatide With Basal Insulin Helped Type 2 Diabetes Patients With Uncontrolled HbA1c Achieve Target Blood Glucose Levels; Lixisenatide Marketing Authorization Application Submitted to European Medi ...

TiGenix: National Reimbursement in the Netherlands Obtained for Breakthrough Cartilage Therapy ChondroCelect(R)

LEUVEN, BELGIUM: LEUVEN, BELGIUM -- (Marketwire) -- 06/08/12 -- TiGenix (EURONEXT BRUSSELS: TIG)TiGenix (EURONEXT BRUSSELS: TIG) announced today that its innovative cartilage repair therapy ChondroCelect® has obtai ...

Sunshine Heart Receives Health Canada Approval to Modify Its Ongoing Investigational Study to Use the Next Generation C-Pulse(R) System Driver

SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN: SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN -- (Marketwire) -- 06/07/12 -- Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC), a global medical device company focused on innovative technologies for moderate t ...

Immunovative Inc. Announces Dr. Michael Har-Noy's Grand Rounds Presentation at Northwestern University

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 06/07/12 -- Immunovative Inc. ("Immunovative") (OTCBB: IMUN) today announced that Dr. Michael Har-Noy, Founder and Chief Executive Officer of Immunovative T ...

Seite 197 von 255: 1 « .. 196 197 198 199 200 201 202 203 204 205 .. » 255